Prothena Corporation plc Live Stock Price Today, Share Analysis and Chart

Name: Prothena Corporation plc: Is Infosys Ltd. worth buying?
Item: Prothena Corporation plc
Rating: 1.59775
Author: Trendlyne DVM scores

about

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseas...

9.75 -0.13 (-1.32%)

48.36% Fall from 52W High

349.0K

XNAS Volume

XNAS 23 Oct, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

15.5 / 100

Technically Neutral

48.4 / 100

1Yr Price target upside is 33%

6 analysts

Prothena Corporation plc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Prothena Corporation plc Live Stock Price Today, Share Analysis and Chart

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseas...

48.36% Fall from 52W High

SWOT Analysis

Prothena Corporation plc Live Price Chart